TG Therapeutics annual meeting: all proposals pass; say-on-pay gets 54.5% support, director Lonial 54.1%

TG THERAPEUTICS, INC.

Six directors elected; Sagar Lonial, MD had lowest support (54.12% for, 40.5M withheld).
KPMG ratified as independent auditor for FY2025 with 117.8M for (99.6% approval).
Advisory vote on named executive officer compensation passed with 47.9M for (54.5% of votes cast).
2022 Incentive Plan amended to increase authorized shares from 17M to 22M (82.0M for vs 5.8M against).
Quorum of 118.4M shares (74.58%) represented at meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.